期刊文献+

Real time monitoring of bioreactor mAb IgG3 cell culture process dynamics via Fourier transform infrared spectroscopy: Implications for enabling cell culture process analytical technology

Real time monitoring of bioreactor mAb IgG3 cell culture process dynamics via Fourier transform infrared spectroscopy: Implications for enabling cell culture process analytical technology
原文传递
导出
摘要 Compared to small molecule process analytical technology (PAT) applications, biotechnology product PAT applications have certain unique challenges and opportunities. Understanding process dynamics of bioreactor cell culture process is essential to establish an appropriate process control strategy for biotechnology product PAT applications. Inline spectroscopic techniques for real time monitoring of bioreactor cell culture process have the distinct potential to develop PAT approaches in manufac- turing biotechnology drug products. However, the use of inline Fourier transform infrared (FTIR) spectroscopic techniques for bioreactor cell culture process monitoring has not been reported. In this work, real time inline FTIR Spectroscopy was applied to a lab scale bioreactor mAb IgG3 cell culture fluid biomolecular dynamic model. The technical feasibility of using FTIR Spectroscopy for real time tracking and monitoring four key cell culture metabolites (including glucose, glutamine, lactate, and ammonia) and protein yield at increasing levels of complexity (simple binary system, fully formulated media, actual bioreactor cell culture process) was evaluated via a stepwise approach. The FTIR fingerprints of the key metabolites were identified. The multivariate partial least squares (PLS) calibration models were established to correlate the process FTIR spectra with the concentrations of key metabolites and protein yield of in-process samples, either individually for each metabolite and protein or globally for all four metabolites simultaneously. Applying the 2'ld derivative pre-processing algorithm to the FTIR spectra helps to reduce the number of PLS latent variables needed significantly and thus simplify the interpretation of the PLS models. The validated PLS models show promise in predicting the concentration profiles of glucose, glutamine, lactate, and ammonia and protein yield over the course of the bioreactor cell culture process. Therefore, this work demonstrated the technical feasibility of real time monitoring of the bioreactor cell culture process via FTIR spectroscopy. Its implications for enabling cell culture PAT were discussed. Compared to small molecule process analytical technology (PAT) applications, biotechnology product PAT applications have certain unique challenges and opportunities. Understanding process dynamics of bioreactor cell culture process is essential to establish an appropriate process control strategy for biotechnology product PAT applications. Inline spectroscopic techniques for real time monitoring of bioreactor cell culture process have the distinct potential to develop PAT approaches in manufac- turing biotechnology drug products. However, the use of inline Fourier transform infrared (FTIR) spectroscopic techniques for bioreactor cell culture process monitoring has not been reported. In this work, real time inline FTIR Spectroscopy was applied to a lab scale bioreactor mAb IgG3 cell culture fluid biomolecular dynamic model. The technical feasibility of using FTIR Spectroscopy for real time tracking and monitoring four key cell culture metabolites (including glucose, glutamine, lactate, and ammonia) and protein yield at increasing levels of complexity (simple binary system, fully formulated media, actual bioreactor cell culture process) was evaluated via a stepwise approach. The FTIR fingerprints of the key metabolites were identified. The multivariate partial least squares (PLS) calibration models were established to correlate the process FTIR spectra with the concentrations of key metabolites and protein yield of in-process samples, either individually for each metabolite and protein or globally for all four metabolites simultaneously. Applying the 2'ld derivative pre-processing algorithm to the FTIR spectra helps to reduce the number of PLS latent variables needed significantly and thus simplify the interpretation of the PLS models. The validated PLS models show promise in predicting the concentration profiles of glucose, glutamine, lactate, and ammonia and protein yield over the course of the bioreactor cell culture process. Therefore, this work demonstrated the technical feasibility of real time monitoring of the bioreactor cell culture process via FTIR spectroscopy. Its implications for enabling cell culture PAT were discussed.
出处 《Frontiers of Chemical Science and Engineering》 SCIE EI CAS CSCD 2015年第3期386-406,共21页 化学科学与工程前沿(英文版)
关键词 process analytical technology (PAT) Fouriertransform infrared (FTIR) spectroscopy partial least squares (PLS) regression mouse IgG3 bioreactor cell culture process real time process monitoring process analytical technology (PAT), Fouriertransform infrared (FTIR) spectroscopy, partial least squares (PLS) regression, mouse IgG3, bioreactor cell culture process, real time process monitoring
  • 相关文献

参考文献32

  • 1FDA/ICH. Guidance for Industry Q 11 Development and Manufac- ture of Drug Substances. FDA, 2012. Available at: http://www.fda. gov/downloads/Drugs/Guidances/UCM261078.pdf (accessed on 07/28/2015).
  • 2FDA. Guidance for Industry PAT--A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assur- ance. FDA, 2004. Available at: http://www.fda.gov/downloads/Drugs/Guidances/ucm070305.pdf (accessed on 07/28/2015).
  • 3FDA. Advancing Regulatory Science at FDA: A Strategic Plan. FDA, 2011. Available at: http://www.fda.gov/downloads/sciencer- esearch/specialtopics/regulatoryscience/ucm268225.pdf (accessed on 07/28/2015).
  • 4Wu H Q, Khan M A, Hussain A S. Process control perspective for process analytical technology: Integration of chemical engineering practice into semiconductor and pharmaceutical industries. Chemi- cal Engineering Communications, 2007, 194(6): 760-779.
  • 5Read E K, Park J T, Shah R B, Riley B S, Brorson K A, Rathore A S. Process analytical technology (PAT) for biopharmaceutical pro- ducts: Part I. Concepts and applications. Biotechnology and Bioengineering, 2010, 105(2): 276-284.
  • 6Glassey J, Gernaey K V, Clemens C, Schulz T W, Oliveira R, Striedner G, Mandenius C F. Process analytical technology (PAT) for biopharmaceuticals. Biotechnology Journal, 2011, 6(4): 369- 377.
  • 7Simon L L, Pataki H, Marosi G, Meemken F, Hungerbtihler K, Balker A, Tummala S, Glennon B, Kuentz M, Steele G, Kramer H J M, Rydzak J W, Chen Z, Morris J, Kjell F, Singh R, Gani R, Gemaey K V, Louhi-Kultanen M, O'Reilly J, Sandier N, Antikainen O, Ylimusi J, Frohberg P, Ulrich J, Braatz R D, Leyssens T, von Stosch M, Oliveira R, Tan R B H, Wu H, l~an M, O'Grady D, Pandey A, Westra R, Delle-Case E, Pape D, Angelosante D, Maret Y, Steiger O, Lenner M, Abbou-Oucherif K, Nagy Z K, Litster J D, Kamaraju V K, Chiu M S. Assessment of recent process analytical technology (PAT) trends: A multiauthor review. Organic Process Research & Development, 2015, 19(1): 3~62.
  • 8Wu H, Dong Z, Li H, Khan M A. An integrated process analytical technology (PAT) approach for pharmaceutical crystallization process understanding to ensure product quality and safety: FDA scientist's perspective. Organic Process Research & Development, 2015, 19(1): 89-101.
  • 9Wu H, Heilweil E, Hussain A S, Khan M A. Process analytical technology (PAT): Quantification approaches in Terahertz spectro- scopy for pharmaceutical application. Journal of Pharmaceutical Sciences, 2007, 97(2): 970 984.
  • 10Wu H, Khan M A. THz spectroscopy: An emerging technology for pharmaceutical development and pharmaceutical process analytical technology (PAT) applications. Journal of Molecular Structure, 2012, 1020:112 120.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部